Literature DB >> 28474969

HLA-DRB1*04:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis.

Koji Shinoda1, Takuya Matsushita1, Yuri Nakamura1, Katsuhisa Masaki1, Ryo Yamasaki1, Hiroo Yamaguchi1, Osamu Togao2, Akio Hiwatashi2, Jun-Ichi Kira1.   

Abstract

BACKGROUND: Cortical lesions (CLs) frequently observed in Caucasian patients with multiple sclerosis (MS) contribute to disability. However, it remains unclear whether CLs are associated with clinical features and genetic risk factors, such as HLA-DRB1*15:01 and -DRB1*04:05 in Asian MS patients.
OBJECTIVE: To elucidate the frequency of CLs and their association with HLA-DRB1 and DPB1 alleles in Japanese MS patients.
METHODS: Three-dimensional double inversion recovery imaging and clinical information were retrospectively obtained from 92 Japanese MS patients.
RESULTS: CLs of any type, intracortical lesions (ICLs), and leukocortical lesions (LCLs) were detected in 39.1%, 26.1%, and 28.3% of patients, respectively. MS patients with ICLs had a significantly higher frequency of secondary progression and greater Expanded Disability Status Scale (EDSS) scores than those without ICLs. Similar trends were observed with CLs and LCLs. The number of all three lesion types positively correlated with EDSS scores. The frequency and number of ICLs were significantly higher in HLA-DRB1*15:01 carriers than in HLA-DRB1*15:01 non-carriers, but significantly lower in HLA-DRB1*04:05 carriers than in HLA-DRB1*04:05 non-carriers. Multivariate logistic regression analysis revealed a negative association of HLA-DRB1*04:05 with ICLs.
CONCLUSION: ICLs are associated with greater disease severity in Japanese MS patients and are partly suppressed by the HLA-DRB1*04:05 allele.

Entities:  

Keywords:  HLA-DRB1*04:05; HLA-DRB1*15:01; Japanese; cortical lesion; double inversion recovery image; intracortical lesion

Mesh:

Substances:

Year:  2017        PMID: 28474969     DOI: 10.1177/1352458517707067

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  4 in total

1.  Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis.

Authors:  Koji Shinoda; Takuya Matsushita; Yuri Nakamura; Katsuhisa Masaki; Shiori Sakai; Haruka Nomiyama; Osamu Togao; Akio Hiwatashi; Masaaki Niino; Noriko Isobe; Jun-Ichi Kira
Journal:  Sci Rep       Date:  2020-03-23       Impact factor: 4.379

2.  A new clustering method identifies multiple sclerosis-specific T-cell receptors.

Authors:  Fumie Hayashi; Noriko Isobe; Jacob Glanville; Takuya Matsushita; Guzailiayi Maimaitijiang; Shoko Fukumoto; Mitsuru Watanabe; Katsuhisa Masaki; Jun-Ichi Kira
Journal:  Ann Clin Transl Neurol       Date:  2021-01-05       Impact factor: 4.511

3.  HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.

Authors:  Mitsuru Watanabe; Yuri Nakamura; Shinya Sato; Masaaki Niino; Hikoaki Fukaura; Masami Tanaka; Hirofumi Ochi; Takashi Kanda; Yukio Takeshita; Takanori Yokota; Yoichiro Nishida; Makoto Matsui; Shigemi Nagayama; Susumu Kusunoki; Katsuichi Miyamoto; Masanori Mizuno; Izumi Kawachi; Etsuji Saji; Takashi Ohashi; Shun Shimohama; Shin Hisahara; Kazutoshi Nishiyama; Takahiro Iizuka; Yuji Nakatsuji; Tatsusada Okuno; Kazuhide Ochi; Akio Suzumura; Ken Yamamoto; Yuji Kawano; Shoji Tsuji; Makoto Hirata; Ryuichi Sakate; Tomonori Kimura; Yuko Shimizu; Akiko Nagaishi; Kazumasa Okada; Fumie Hayashi; Ayako Sakoda; Katsuhisa Masaki; Koji Shinoda; Noriko Isobe; Takuya Matsushita; Jun-Ichi Kira
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.

Authors:  Yuri Nakamura; Laura Gaetano; Takuya Matsushita; Altermatt Anna; Till Sprenger; Ernst-Wilhelm Radue; Jens Wuerfel; Lorena Bauer; Michael Amann; Koji Shinoda; Noriko Isobe; Ryo Yamasaki; Takahiko Saida; Ludwig Kappos; Jun-Ichi Kira
Journal:  J Neuroinflammation       Date:  2018-09-05       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.